| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | 24.342 | 51.534 | 29.097 | 0 | 0 | - | - | - | - |
| Total Income - EUR | - | 24.342 | 51.534 | 29.097 | 0 | 0 | - | - | - | - |
| Total Expenses - EUR | - | 18.952 | 45.481 | 30.981 | 1.202 | 675 | - | - | - | - |
| Gross Profit/Loss - EUR | - | 5.390 | 6.053 | -1.884 | -1.202 | -675 | - | - | - | - |
| Net Profit/Loss - EUR | - | 4.689 | 5.537 | -2.175 | -1.202 | -675 | - | - | - | - |
| Employees | - | 0 | 3 | 2 | 0 | 0 | - | - | - | - |
Check the financial reports for the company - Nyks Lab Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | 3.990 | 5.193 | 3.236 | 2.012 | 1.299 | - | - | - | - |
| Current Assets | - | 2.426 | 11.550 | 8.230 | 5.459 | 5.356 | - | - | - | - |
| Inventories | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Receivables | - | 0 | 0 | 605 | 0 | 0 | - | - | - | - |
| Cash | - | 2.426 | 11.550 | 7.625 | 5.459 | 5.356 | - | - | - | - |
| Shareholders Funds | - | 4.733 | 10.191 | 7.829 | 6.475 | 5.677 | - | - | - | - |
| Social Capital | - | 45 | 44 | 43 | 42 | 41 | - | - | - | - |
| Debts | - | 1.682 | 6.552 | 3.638 | 996 | 977 | - | - | - | - |
| Income in Advance | - | 0 | 0 | 0 | 0 | 0 | - | - | - | - |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "3250 - 3250" | |||||||||
| CAEN Financial Year |
3250
|
|||||||||
Comments - Nyks Lab Srl